Gufic Biosciences receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
Marks the World Head & Neck Cancer Day at the OCTF Conference
The zero-observation outcome reflects the company's robust quality management systems and commitment to excellence in its operations.
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Convergent action on AMR identified as an important area of intervention
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
Digitization has unleashed a flood of data that presents a huge opportunity but is also overwhelming clinicians, nurses, and administrators
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
Subscribe To Our Newsletter & Stay Updated